certify

Marina Turea Marina is passionate about all emerging technologies in the healthcare space and love to write about all of them.

March 26, 2023 439 Views
Although Ipsen’s Palovarotene was rejected by the FDA just three months ago, the rare disease candidate’s story is ...
banner
Adsense